DD295840A5 - 1-ethylphenoxathiin-10, 10-dioxid, verfahren zu seiner herstellung und pharmazeutische zusammensetzung - Google Patents

1-ethylphenoxathiin-10, 10-dioxid, verfahren zu seiner herstellung und pharmazeutische zusammensetzung Download PDF

Info

Publication number
DD295840A5
DD295840A5 DD90344071A DD34407190A DD295840A5 DD 295840 A5 DD295840 A5 DD 295840A5 DD 90344071 A DD90344071 A DD 90344071A DD 34407190 A DD34407190 A DD 34407190A DD 295840 A5 DD295840 A5 DD 295840A5
Authority
DD
German Democratic Republic
Prior art keywords
dioxide
hydrogen
compound
ethylphenoxathiin
mao
Prior art date
Application number
DD90344071A
Other languages
German (de)
English (en)
Inventor
Morton Harfenist
Gee Daniel P C Mc
Helen L White
Barret R Cooper
Jonathan R T Davidson
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD295840A5 publication Critical patent/DD295840A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06Six-membered rings
    • C07D327/08[b,e]-condensed with two six-membered carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD90344071A 1989-09-18 1990-09-17 1-ethylphenoxathiin-10, 10-dioxid, verfahren zu seiner herstellung und pharmazeutische zusammensetzung DD295840A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898921069A GB8921069D0 (en) 1989-09-18 1989-09-18 Pharmaceutically active compound,preparation and use

Publications (1)

Publication Number Publication Date
DD295840A5 true DD295840A5 (de) 1991-11-14

Family

ID=10663238

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90344071A DD295840A5 (de) 1989-09-18 1990-09-17 1-ethylphenoxathiin-10, 10-dioxid, verfahren zu seiner herstellung und pharmazeutische zusammensetzung

Country Status (18)

Country Link
US (1) US5420156A (fi)
EP (1) EP0419157A3 (fi)
JP (1) JPH03145486A (fi)
KR (1) KR940000074B1 (fi)
AU (1) AU643701B2 (fi)
CA (1) CA2025524A1 (fi)
DD (1) DD295840A5 (fi)
FI (1) FI88794C (fi)
GB (1) GB8921069D0 (fi)
HU (1) HU207065B (fi)
IE (1) IE903355A1 (fi)
IL (1) IL95709A (fi)
MC (1) MC2152A1 (fi)
MX (1) MX9203221A (fi)
NO (1) NO175746C (fi)
NZ (1) NZ235343A (fi)
PT (1) PT95327A (fi)
ZA (1) ZA907398B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8921069D0 (en) * 1989-09-18 1989-11-01 Wellcome Found Pharmaceutically active compound,preparation and use
KR930701997A (ko) * 1990-09-17 1993-09-08 엘.디.젠킨스 항우울제로서의 1-치환된 페녹사티인 유도체
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US6110961A (en) * 1996-09-11 2000-08-29 Krenitsky Pharmaceuticals, Inc. Phenoxathin derivatives as inhibitors of monoamine oxidase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997422A (en) * 1959-01-09 1961-08-22 Smith Kline French Lab Monoamine oxidase inhibition
AU2843377A (en) * 1972-05-19 1979-03-08 Wellcome Found Phenoxathiin dioxides
GB1447032A (en) * 1972-05-19 1976-08-25 Wellcome Found Tricyclic sulphones and pharmaceutical compositions containing them
US4091108A (en) * 1972-09-06 1978-05-23 Burroughs Wellcome Co. Antiallergic pharmaceutical composition and use
FR2239025B1 (fi) * 1973-07-25 1982-07-02 Souriau & Cie
DE2339617A1 (de) * 1973-08-04 1975-02-20 Merck Patent Gmbh Sulfoxide und sulfone sowie verfahren zu ihrer herstellung
US4012517A (en) * 1975-01-24 1977-03-15 Burroughs Wellcome Co. Compositions and treatment
EP0068563A3 (en) * 1981-06-23 1983-06-15 THE PROCTER & GAMBLE COMPANY Heterocyclic acetic acid compounds and compositions for treating bone diseases
EP0150891A1 (en) * 1984-01-05 1985-08-07 The Wellcome Foundation Limited Tricyclic compounds, processes for their preparation, compositions containing such compounds and their use in medicine
EP0270252A3 (en) * 1986-11-11 1990-04-04 Imperial Chemical Industries Plc Derivatives of propenoic acids used in agriculture
JPH01294718A (ja) * 1987-12-15 1989-11-28 Nippon Oil & Fats Co Ltd 新規な透明樹脂、高屈折率透明光学用樹脂、塗料用樹脂及び単量体
GB8921069D0 (en) * 1989-09-18 1989-11-01 Wellcome Found Pharmaceutically active compound,preparation and use

Also Published As

Publication number Publication date
US5420156A (en) 1995-05-30
JPH03145486A (ja) 1991-06-20
MC2152A1 (fr) 1992-03-10
PT95327A (pt) 1991-05-22
NO904034D0 (no) 1990-09-17
FI88794C (fi) 1993-07-12
HUT58068A (en) 1992-01-28
IL95709A (en) 1995-03-30
IE903355A1 (en) 1991-04-10
FI904560A0 (fi) 1990-09-17
FI88794B (fi) 1993-03-31
NO904034L (no) 1991-03-19
EP0419157A2 (en) 1991-03-27
KR940000074B1 (ko) 1994-01-05
NO175746C (no) 1994-11-30
KR910006270A (ko) 1991-04-29
AU6265390A (en) 1991-03-21
NZ235343A (en) 1992-08-26
HU905928D0 (en) 1991-03-28
AU643701B2 (en) 1993-11-25
MX9203221A (es) 1992-07-01
HU207065B (en) 1993-03-01
NO175746B (no) 1994-08-22
CA2025524A1 (en) 1991-03-19
ZA907398B (en) 1992-05-27
EP0419157A3 (en) 1991-08-28
GB8921069D0 (en) 1989-11-01

Similar Documents

Publication Publication Date Title
EP0163965B1 (de) Pyridazinone, ihre Herstellung und Verwendung, Pyridazinone enthaltende Arzeimittel
EP1198453B1 (de) N-(indolcarbonyl-)piperazinderivate als 5-ht2a-rezeptor liganden
DE2901477A1 (de) Thienohydantoinderivate und diese enthaltende arzneimittel
EP0148440A1 (de) 1,3,4,5-Tetrahydrobenz[c,d]indole, ein Verfahren zu ihrer Herstellung und ihre Verwendung
DE69908421T2 (de) Pharmazeutische zusammensetzung enthaltend eine kombination der dextro- und laevo-isomeren von sotalol
EP0157267A2 (de) Substituierte Benzopyrane, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
WO1999025716A9 (de) Pyranone, verfahren zu ihrer herstellung und verwendung
DE2438399C3 (de) a-substituierte Benzhydrolderivate und ihre Salze, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben
EP0056057A1 (de) Substituierte adenosin-3',5'-phosphorsäurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2941869A1 (de) Dibenzothiepinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DD295840A5 (de) 1-ethylphenoxathiin-10, 10-dioxid, verfahren zu seiner herstellung und pharmazeutische zusammensetzung
DE1470074C3 (de) 1,2,3,4,6,7-Hexahydro-l lbH-benzo eckige Klammer auf a eckige Klammer zu chinolizine sowie deren Acetate und/oder phsiologisch verträgliche Säureadditionssalze sowie Verfahren zu ihrer Herstellung
DE1909406C3 (de) Tricyclische Verbindungen
DE69021525T2 (de) Pyrrolaldehydderivate.
EP0496274B1 (de) Tricyclisches Pyridonderivat
DD202158A5 (de) Verfahren zur herstellung von imidazolin-derivaten
DE2646213A1 (de) Aroylphenylnaphthaline und verfahren zu ihrer herstellung
EP0024616B1 (de) 1-(3'-Acyloxyphenyl)-2-aminoethanole, deren Säureadditionssalze, diese enthaltende Arzneimittel, sowie Verfahren zu ihrer Herstellung
DE2234250A1 (de) Neue substituierte xanthoncarbonsaeureverbindungen
DE4405641C2 (de) Pharmazeutische Zusammensetzung, enthaltend 2-(4-Methoxyphenoxy)-3-pyridinamin
DE2114230A1 (de) Psychotropes Praeparat und Verfahren zur Herstellung seines Wirkstoffes
DD267978A5 (de) Verfahren zur herstellung von hydroxamsaeure-arylderivaten
AT353272B (de) Verfahren zur herstellung von neuen piperidin- derivaten sowie von deren salzen und optisch aktiven formen
EP0802181B1 (de) Neue Retinoide
DD231352A5 (de) Verfahren zur herstellung tricyclischer verbindungen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee